文献速递食管胃疾病与幽门螺杆菌消化道肿瘤与早癌消化内镜

幽门螺杆菌感染和血清胃蛋白酶原水平与内镜切除术后异时性胃肿瘤风险相关

Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.
PubMed 文献 · Aliment Pharmacol Ther · 2017-08-11

该回顾性研究纳入2008年1月至2013年5月在韩国一家三级中心因早期胃癌行内镜黏膜下剥离术的590例连续患者,分析幽门螺杆菌感染和血清胃蛋白酶原水平与异时性胃肿瘤的关系。中位随访47.7个月,64例发生异时性胃肿瘤;持续幽门螺杆菌感染(HR 2.532)和PGI:PGII比值≤3(HR 1.881)是危险因素,根除幽门螺杆菌可降低风险。

要点

  • 持续幽门螺杆菌感染是异时性胃肿瘤的危险因素(HR 2.532,P=.022)。
  • 内镜黏膜下剥离术时血清PGI:PGII比值≤3增加异时性胃肿瘤风险(HR 1.881,P=.018)。
  • 根除幽门螺杆菌感染可降低异时性胃肿瘤风险。

核心结论

  • 在因早期胃癌行内镜切除术患者的回顾性分析中,根除幽门螺杆菌感染可降低异时性胃肿瘤风险。
  • 血清PGI:PGII比值≤3也增加内镜黏膜下剥离术后异时性胃肿瘤风险。

研究设计与样本

  • 回顾性研究纳入2008年1月至2013年5月在韩国一家三级中心因早期胃癌行内镜黏膜下剥离术的590例连续患者。
  • 在内镜黏膜下剥离术时测量血清胃蛋白酶原水平并记录幽门螺杆菌感染状态;对证实当前幽门螺杆菌感染者给予根除治疗。
  • 术后3个月、9个月及之后每年复查内镜检测肿瘤并检测幽门螺杆菌感染,其中442例在这些时间点测量血清胃蛋白酶原水平。

主要发现

  • 中位随访47.7个月期间,64例患者发生异时性胃肿瘤。
  • 主队列(n=590)多因素分析中,异时性胃肿瘤的危险因素包括持续幽门螺杆菌感染(HR 2.532,P=.022)和内镜黏膜下剥离术时血清PGI:PGII比值≤3(HR 1.881,P=.018)。
  • 在测量血清胃蛋白酶原的患者中,持续幽门螺杆菌感染(OR 4.404,P=.009)和平均血清PGI:PGII比值持续降至≤3(OR 2.141,P=.039)与异时性胃肿瘤风险增加相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients who have undergone endoscopic resection of early gastric cancers (EGCs) are at risk for metachronous gastric neoplasm. AIM: To determine whether serum level of pepsinogen (PG), a marker of gastric atrophy, can determine which patients who have undergone endoscopic submucosal dissection for EGC are at risk for metachronous gastric neoplasm. We also investigated the effects of Helicobacter pylori eradication on metachronous gastric neoplasm incidence. METHODS: We performed a retrospective study of 590 consecutive patients who underwent endoscopic submucosal dissection for EGC, from January 2008 to May 2013 at a tertiary centre in South Korea; serum levels of PG were measured at the time of endoscopic submucosal dissection and H. pylori infection status were recorded. In case of proven presence of current H. pylori infection, eradication treatment was provided. Patients underwent follow-up endoscopies at 3 months, 9 months, and each year after the procedure to detect neoplasms and were tested for H. pylori infection; serum levels of PG were measured at these time points from 442 of the patients. The main and sub-cohorts were assessed for baseline characteristics, H. pylori infection, serum level of PG, and metachronous gastric neoplasm lesions. RESULTS: During a median follow-up period of 47.7 months, 64 patients developed metachronous gastric neoplasms. In multivariate analysis of the main cohort (n = 590), risk factors for metachronous gastric neoplasm included persistent H. pylori infection (hazard ratio [HR], 2.532; P = .022) and serum ratio of PGI:PGII of three or less at the time of endoscopic submucosal dissection (HR, 1.881; P = .018). Among patients with serum PG measurements, persistent H. pylori infection (odds ratio [OR], 4.404; P = .009) and persistent decrease in mean serum ratio of PGI:PGII to 3 or less were associated with increased risk of metachronous gastric neoplasm (OR, 2.141; P = .039). CONCLUSIONS: In a retrospective analysis of patients who underwent endoscopic resection of EGCs, eradication of H. pylori infection reduced risk for metachronous gastric neoplasm. Serum ratio of PGI:PGII of 3 or less also increase risk of metachronous gastric neoplasm after endoscopic submucosal dissection. ClinicalTrials.gov. registry number, NCT02682446.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Kwon Y, Jeon S, Nam S, et al. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection. Aliment Pharmacol Ther. 2017. PMID: 28799258. doi:10.1111/apt.14263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。